{"id":2586,"date":"2024-01-28T06:46:36","date_gmt":"2024-01-28T07:46:36","guid":{"rendered":"https:\/\/faranshimi.com\/en\/?post_type=portfolio&p=2586"},"modified":"2024-04-23T13:28:36","modified_gmt":"2024-04-23T13:28:36","slug":"empagliflozin","status":"publish","type":"portfolio","link":"https:\/\/faranshimi.com\/en\/portfolio\/empagliflozin\/","title":{"rendered":"Empagliflozin"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), inhibiting glucose reabsorption in the kidney, thereby increasing urinary glucose excretion. Once daily dose is sufficient due to its long-lasting effect.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"featured_media":2403,"template":"","portfolio-category":[15],"class_list":["post-2586","portfolio","type-portfolio","status-publish","has-post-thumbnail","hentry","portfolio-category-active-pharmaceutical-ingredient-products"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/faranshimi.com\/en\/wp-json\/wp\/v2\/portfolio\/2586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faranshimi.com\/en\/wp-json\/wp\/v2\/portfolio"}],"about":[{"href":"https:\/\/faranshimi.com\/en\/wp-json\/wp\/v2\/types\/portfolio"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/faranshimi.com\/en\/wp-json\/wp\/v2\/media\/2403"}],"wp:attachment":[{"href":"https:\/\/faranshimi.com\/en\/wp-json\/wp\/v2\/media?parent=2586"}],"wp:term":[{"taxonomy":"portfolio-category","embeddable":true,"href":"https:\/\/faranshimi.com\/en\/wp-json\/wp\/v2\/portfolio-category?post=2586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}